Delivery Order SPE2DB20D9331-SPE2DB25FL0V0

Award Date 2/28/25
Potential Completion Date 3/21/25
Potential Value $62K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $53,318.23 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4560266971 MACI 3CM X 5CM IMPLANT SHEETS and has a completion date of February 23, 2023. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications and medical supplies to support the recurring...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is a firm fixed-price delivery order valued at $46,119.30. It was issued by the Defense Logistics Agency (DLA) under the SPE2DB program, a $499,999,999 indefinite delivery contract that covers a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military healthcare facilities worldwide. The award is for the delivery of MACI 3CM X...
This federal contract award, valued at $49,714.55, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a delivery order under the DLA's SPE2DB program, a $499,999,999 indefinite delivery contract that provides a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of Department of Defense (DoD) healthcare facilities worldwide. This...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth up to $57,317.20 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, which has a period of performance through April 16, 2024, is for the supply of MACI 3CM X 5CM Implant Sheets. This order was placed under DMS Pharmaceutical Group's existing Indefinite Delivery Vehicle (IDV) contract SPE2DB24FSW93 with DLA, which has a ceiling value of up...
This federal contract award, valued at $61,902.90, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the provision of MACI 3CM X 5CM IMPLANT SHEETS, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This federal contract award, valued at $57,317.20, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order under the DLA's SPE2DB indefinite delivery contract (IDC), which has a ceiling value of $499,999,999 and is valid through November 2026. The contract is for the delivery of 4566653511 MACI 3cm x 5cm implant sheets, a specialized...
The federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is for the delivery of MACI 3CM X 5CM IMPLANT SHEETS to the Defense Logistics Agency (DLA). The firm fixed-price delivery order, valued at $57,317.20, is not associated with a set-aside designation. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $61,902.90 firm fixed-price delivery order is for the provision of MACI 3CM X 5CM IMPLANT SHEETS and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $57,317.20 and covers the provision of MACI 3CM X 5CM IMPLANT SHEETS, a specialized medical product. The contract is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $61,902.90 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4567084856 MACI 3CM X 5CM IMPLANT SHEETS, a specialized medical product, with a completion date of February 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB25FL0V0
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC). The contract, valued at $61,902.91, is for the delivery of MACI 3CM X 5CM IMPLANT SHEETS to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of pharmaceutical products and medical supplies, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This contract is not associated with any set-aside designations, allowing DMS Pharmaceutical Group Inc. to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains. The company also holds a significant single-award IDC with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, further positioning it as a crucial supplier in the federal pharmaceutical supply chain.

Generated 5/30/25, 9:55 AM